TARO PHARMACEUTICAL INDUS (TARO) Forecast, Price Target & Analyst Ratings

NYSE:TARO • IL0010827181

Current stock price

42.97 USD
0 (0%)
At close:
42.97 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TARO PHARMACEUTICAL INDUS (TARO).

Forecast Snapshot

Consensus Price Target

Price Target
$43.86
+ 2.07% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 24, 2024
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$43.86
Upside
+ 2.07%
From current price of $42.97 to mean target of $43.86, Based on 6 analyst forecasts
Low
$43.43
Median
$43.86
High
$45.15

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for TARO. The average price target is 43.86 USD. This implies a price increase of 2.07% is expected in the next year compared to the current price of 42.97.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

TARO Current Analyst RatingTARO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

TARO Historical Analyst RatingsTARO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
TARO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about TARO.
In the previous month the buy percentage consensus was at a similar level.
TARO was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-01-18HC Wainwright & Co.Downgrade Buy -> Neutral
2023-01-25HC Wainwright & Co.Maintains Buy
2022-08-15HC Wainwright & Co.Maintains Buy
2022-01-31HC Wainwright & Co.Maintains Buy
2022-01-18HC Wainwright & Co.Maintains Buy
2021-07-28HC Wainwright & Co.Maintains Buy
2021-06-02HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 24, 2024

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024
Revenue
YoY % growth
TARO revenue by date.TARO revenue by date.
561.3M
2.24%		573M
2.08%		629.182M
9.80%
EBITDA
YoY % growth
TARO ebitda by date.TARO ebitda by date.
150.9M
-10.60%		49.8M
-67.00%		52.602M
5.63%
EBIT
YoY % growth
TARO ebit by date.TARO ebit by date.
125M
-13.85%		17.7M
-85.84%		21.508M
21.51%
Operating Margin
TARO operating margin by date.TARO operating margin by date.
22.27%3.09%3.42%
EPS
YoY % growth
TARO eps by date.TARO eps by date.
3.18
131.45%		1.03
-67.61%		1.72
66.99%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

TARO Yearly Revenue VS EstimatesTARO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
TARO Yearly EPS VS EstimatesTARO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

TARO PHARMACEUTICAL INDUS / TARO Forecast FAQ

Can you provide the average price target for TARO PHARMACEUTICAL INDUS stock?

6 analysts have analysed TARO and the average price target is 43.86 USD. This implies a price increase of 2.07% is expected in the next year compared to the current price of 42.97.

What is the next earnings date for TARO stock?

TARO PHARMACEUTICAL INDUS (TARO) will report earnings on 2024-07-24, after the market close.

What is the consensus rating for TARO PHARMACEUTICAL INDUS (TARO) stock?

The consensus rating for TARO PHARMACEUTICAL INDUS (TARO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.